Listing 1 - 10 of 74 | << page >> |
Sort by
|
Choose an application
Choose an application
"Liver steatosis or nonalcoholic fatty liver disease (NAFLD) is a progressive disorder characterized by the fat accumulation in the parenchyma of the liver. The progressive form of NAFLD called nonalcoholic steatohepatitis (NASH) is the advanced condition that shows different grades of fibrosis, which could progress to cirrhosis, hepatocellular carcinoma and liver-related morbidity and mortality. Bariatric surgery gains attention as a potential treatment for liver steatosis because different studies revealed an improvement in 90% of cases of fatty liver after surgery. The improvement occurred within the first year and persisted up to five years. Pathogenic mechanisms that are involved in the evolution steatosis are intimately connected with insulin resistance, type 2 diabetes (T2D) and the metabolic syndrome. Bariatric surgery is a powerful treatment to ameliorate all these conditions. The aim of this book is to update the actual evidence about liver steatosis, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in morbidly obese patients, the diagnostic methods and the evolution after the different techniques of bariatric surgery"--
Choose an application
Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis that develops in the absence of competing for liver disease etiologies such as alcohol consumption, monogenic hereditary conditions, or iatrogenic causes. The pathogenesis of NAFLD is multifactorial and its understanding is still incomplete. Although knowledge of the cellular and molecular mechanisms underlying disease development and progression has grown significantly in recent years, the exact contribution of environmental and genetic factors as well as that of extrahepatic and intrahepatic events in determining the disease phenotype remains ill defined. This book discusses topics highly correlated with NAFLD such as the regulation of iron metabolism, the role of the enzyme heparanase in liver steatosis, transcriptional regulation by ERR and its role in pathogenesis, hepatic lipid homeostasis, therapeutic approaches to NAFLD, and pathogenesis and significance of HDL as a molecular modifier in NAFLD.
Choose an application
Choose an application
Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis that develops in the absence of competing for liver disease etiologies such as alcohol consumption, monogenic hereditary conditions, or iatrogenic causes. The pathogenesis of NAFLD is multifactorial and its understanding is still incomplete. Although knowledge of the cellular and molecular mechanisms underlying disease development and progression has grown significantly in recent years, the exact contribution of environmental and genetic factors as well as that of extrahepatic and intrahepatic events in determining the disease phenotype remains ill defined. This book discusses topics highly correlated with NAFLD such as the regulation of iron metabolism, the role of the enzyme heparanase in liver steatosis, transcriptional regulation by ERR and its role in pathogenesis, hepatic lipid homeostasis, therapeutic approaches to NAFLD, and pathogenesis and significance of HDL as a molecular modifier in NAFLD.
Choose an application
This dissertation by Julia Blomdahl explores Non-Alcoholic Fatty Liver Disease (NAFLD), a condition affecting about a quarter of the global population, often linked with type 2 diabetes and obesity. It examines the spectrum of the disease from steatosis to cancer, focusing on the impact of moderate alcohol consumption and genetic factors such as PNPLA3 on disease progression. The research highlights the role of proteomics in differentiating stages of fibrosis, utilizing biomarkers like ACE2, HGF, and IGFBP-7. Through multiple studies, the dissertation provides insights into how moderate alcohol consumption influences fibrosis and NAFLD's progression, advocating for abstention in certain cases. The work is aimed at medical professionals and researchers interested in liver diseases and genetics, proposing potential non-invasive diagnostic approaches.
Fatty liver. --- Fibrosis. --- Fatty liver --- Fibrosis
Choose an application
Choose an application
Choose an application
Choose an application
Listing 1 - 10 of 74 | << page >> |
Sort by
|